Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
J Ethnopharmacol ; 111(1): 155-9, 2007 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-17141996

RESUMEN

Babassu is the popular name of Orbignya phalerata Mart. (Arecaceae). The mesocarp flour obtained from their fruits has been used in Brazil as medicine in the treatment of pains, constipation, obesity, leukemia, rheumatism, ulcerations, tumors, inflammations and venous diseases. The effect of the chronic oral treatment with aqueous extract of babassu mesocarp (500mg/kgday) on the number of platelets, the prothrombin time (PT), the activated partial thromboplastin time (aPTT), the nitric oxide (NO) production and the carrageenin-induced thrombosis was evaluated, using C57Bl/6 mice. The chronic oral treatment with babassu mesocarp induced an anti-thrombotic effect. There was a 88.9% reduction in the necrosis of the tail. This effect seems to be related to an increase in the ability of the macrophage to produce NO and to a slow coagulation process associated to an increase of 12.0 and 13.9% in PT and aPTT, respectively. However, the anti-thrombotic effect seems to be not related to alterations in the number of platelets. It is possible to conclude that the oral treatment with babassu mesocarp has a significant anti-thrombotic effect, which could justify the popular use of babassu mesocarp in the treatment of venous diseases. Meanwhile, this study suggests a potential use of babassu mesocarp as a prophylactic agent to avoid thrombosis events.


Asunto(s)
Arecaceae , Coagulación Sanguínea/efectos de los fármacos , Plaquetas/efectos de los fármacos , Fibrinolíticos/farmacología , Trombosis/prevención & control , Administración Oral , Animales , Brasil , Carragenina , Modelos Animales de Enfermedad , Esquema de Medicación , Fibrinolíticos/administración & dosificación , Frutas , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/metabolismo , Ratones , Ratones Endogámicos C57BL , Necrosis , Óxido Nítrico/metabolismo , Tiempo de Tromboplastina Parcial , Extractos Vegetales/farmacología , Recuento de Plaquetas , Tiempo de Protrombina , Cola (estructura animal)/patología , Trombosis/sangre , Trombosis/inducido químicamente , Trombosis/patología , Factores de Tiempo
2.
Chemotherapy ; 52(2): 91-4, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16462141

RESUMEN

BACKGROUND: Sunflower seed oil (SSO) effect on solid and ascitic forms of Ehrlich tumor was evaluated. METHODS: Solid or ascitic Ehrlich tumor-bearing Swiss mice were treated daily, by subcutaneous route, with 200 microl of SSO. The solid tumor-bearing footpad was measured every 3 days and ascitic tumor-bearing mice had their ascites collected and quantified. At the end of the SSO treatment, the total cell number in lymphoid organs was quantified. RESULTS: Subcutaneous treatment with SSO inhibits the solid tumor growth and increases lymph node cell number in animals with solid tumor, but has no effect on animals with ascitic tumor. CONCLUSIONS: SSO can delay the solid tumor growth, possibly due to better absorption of this treatment by draining lymph nodes.


Asunto(s)
Carcinoma de Ehrlich/tratamiento farmacológico , Aceites de Plantas/uso terapéutico , Animales , Carcinoma de Ehrlich/patología , Inyecciones Subcutáneas , Ratones , Aceites de Plantas/administración & dosificación , Aceite de Girasol
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...